Coya Therapeutics, Inc.

NASDAQ:COYA

Biotechnology

Healthcare
$3.09 -3.18%

-$0.16 today

Market cap
$72.48M
Beta
0.62
P/E (TTM)
-3.9
EPS (TTM)
-$1.26
52W Low $3.71High $7.75

Volume 0.15M

Average 0.16M

COYA Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Coya Therapeutics, Inc.NASDAQ: COYA

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 16.73M shares rose 0.1% year over year, behind the +5.9% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +18.9% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.1% toward the trailing-twelve-month pace of +5.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
16.73M+0.0% QoQ
Last fiscal yearDec 2025
16.73M+9.8% YoY
LTMMar 2026
16.73M+5.9% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.1%——
1 year+9.8%——
3-year CAGR+18.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
16.73M USD
Year-over-year change
+9.8%
4-year CAGR
+26.2%

Weighted Avg Shares vs competitors

How COYA compares with its peers on the latest reported figures

  • COYA's LTM Mar 2026 weighted avg shares of 16.73M shares is the 10th highest of the 11 companies compared; the peer median is 66.1M shares.
  • Its year-over-year change of +5.9% is the 6th highest of 11, against a peer median of +12.4%.
  • Over three fiscal years its annual growth of +18.9% compares with a peer median of +15.7%.
COYA Competitors Peer median
Weighted Avg Shares for COYA and competitors
Company Period LTM YoY 3-year CAGR
CNTXContext Therapeutics Inc.LTM Mar 202694.36M +30.6%+81.3%
STTKShattuck Labs, Inc.LTM Mar 202684.8M +66.7%+18.0%
OVIDOvid Therapeutics Inc.LTM Mar 202674.41M +4.8%+1.5%
ZNTLZentalis Pharmaceuticals, Inc.LTM Mar 202671.52M +0.4%+10.8%
WHWKWhitehawk Therapeutics IncLTM Mar 202668.95M +154.8%+40.1%
MGNXMacroGenics, Inc.LTM Mar 202663.24M +0.8%+0.9%
PLRXPliant Therapeutics, Inc.LTM Mar 202661.49M +1.3%+13.5%
ORMPOramed Pharmaceuticals Inc.LTM Mar 202641.42M +1.6%+2.0%
IMMXImmix Biopharma, Inc.LTM Mar 202634.62M +19.9%+33.4%
COYACoya Therapeutics, Inc.LTM Mar 202616.73M +5.9%+18.9%
CLNNClene Inc.LTM Mar 202610.33M +43.7%+44.6%
Peer median (excluding COYA) 66.1M+12.4%+15.7%

Competitors are the stored peer set for COYA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue006M3.55M7.95M
Cost of Revenue04.41M5.5M11.87M27.36K
Gross Profit0(4.41M)500.68K(8.31M)7.92M
Gross Margin——8.3%-233.9%99.7%
Research & Development2.54M4.94M6.04M11.89M16.73M
Selling, General & Admin2.31M4.85M7.83M8.89M11.45M
Operating Expenses4.87M5.4M8.4M8.94M28.18M
Depreciation & Amortization16.13K27.36K27.36K27.36K27.36K
EBITDA(4.88M)(9.26M)(7.33M)(17.2M)(21.2M)
EBITDA Margin——-122.2%-483.9%-266.8%
Operating Income(4.87M)(9.81M)(7.9M)(17.25M)(20.27M)
Operating Margin——-131.7%-485.4%-255.0%
Interest Income00000
Interest Expense00000
Other Income / Expenses(21.48K)(2.43M)639.37K1.65M(957.4K)
Income Before Tax(4.89M)(12.24M)(7.26M)(15.6M)(21.22M)
Pre-Tax Margin——-121.0%-439.0%-267.1%
Income Tax Expense00723.85K(720.29K)3.09K
Net Income(4.89M)(12.24M)(7.99M)(14.88M)(21.23M)
Net Margin——-133.1%-418.7%-267.1%
EPS (Basic)(0.74)(1.23)(0.79)(0.98)(1.27)
EPS (Diluted)(0.74)(1.23)(0.79)(0.98)(1.27)
Weighted Avg Shares6.6M9.95M10.16M15.24M16.73M
Weighted Avg Shares (Diluted)6.6M9.95M10.16M15.24M16.73M

Coya Therapeutics, Inc.

NASDAQ:COYA

Intrinsic Alpha fair value

Locked

Current Price

$3.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.